brinzolamide


brinzolamide

 [brin-zo´lah-mīd] a inhibitor" >carbonic anhydrase inhibitor used in treatment of open-angle glaucoma and ocular hypertension.

Azopt

A topical carbonic anhydride inhibitor that reduces intraocular pressure, used in patients with ocular hypertension or open-angle glaucoma.
 
Adverse effects
Blurred vision and bitter, sour or unusual taste (5–10% of patients); less commonly, blepharitis, dermatitis, dry eye, foreign body sensation, headache, hyperemia, ocular discharge, ocular discomfort, ocular keratitis, ocular pain, ocular pruritus, rhinitis.

Azopt®

A topical carbonic anhydride inhibitor that decreases intraocular pressure, used in patients with ocular hypertension or open-angle glaucoma.
 
Adverse effects
Blurred vision and bitter, sour or unusual taste (5–10% of patients); less commonly, blepharitis, dermatitis, dry eye, foreign body sensation, headache, hyperemia, ocular discharge, ocular discomfort, ocular keratitis, ocular pain, ocular pruritus or rhinitis.

brinzolamide

A carbonic anhydrase inhibitor drug used in the form of eye drops to control GLAUCOMA. A brand name is Azopt.

carbonic anhydrase inhibitors 

Drugs which inhibit the carbonic anhydrase enzyme in the ciliary epithelium of the ciliary body. This enzyme is essential for the formation of aqueous humour; its reduction results in a decrease in intraocular pressure. Those in use are sulfonamide derivatives. They are administered systemically (e.g. acetazolamide) or topically in the treatment of glaucoma. Examples: acetazolamide, brinzolamide, dichlorphenamide, dorzolamide.